Positron Emission Tomography in Evaluation of DementiaDaniel Silverman, Michael E. Phelps, Mark B. Schapiro et al.|JAMA|2001Cited by 952
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's diseaseGary W. Small, Michael E. Phelps, Linda M. Ercoli et al.|Proceedings of the National Academy of Sciences|2000Cited by 798
Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.Wei Chen, Daniel Silverman, Timothy F. Cloughesy et al.|PubMed|2005Cited by 440
Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapyDaniel Silverman, Patricia A. Ganz, Christine J. Dy et al.|Breast Cancer Research and Treatment|2006Cited by 399
Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [<sup>18</sup>F] Fluorothymidine Positron Emission Tomography: A Pilot StudyWei Chen, Timothy F. Cloughesy, Sibylle Delaloye et al.|Journal of Clinical Oncology|2007Cited by 391